Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Bocchia

Showing results (11-20 of 280) with videos related to

Pageof 28
Sort By:
British Journal of Haematology|February 26, 2016
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphomaEmanuele Cencini, Alberto Fabbri, Monica Bocchia
The Journal of Pathology|May 4, 2017
Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disordersEmanuele Cencini, Alberto Fabbri, Monica Bocchia
Nature Reviews. Clinical Oncology|November 20, 2013
Treatment of smoldering multiple myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
American Journal of Blood Research|July 29, 2021
Nivolumab in relapsed/refractory Hodgkin lymphoma: towards a new treatment strategy?Emanuele Cencini, Monica Bocchia, Alberto Fabbri
Clinical Case Reports|December 28, 2020
Daratumumab efficacy in extramedullary orbital myelomaAlessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Cancer|June 26, 2015
Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphomaAlberto Fabbri, Emanuele Cencini, Monica Bocchia
Medical Oncology (Northwood, London, England)|March 8, 2014
Hodgkin's lymphoma as Richter's transformation in chronic lymphocytic leukemiaAlberto Fabbri, Emanuele Cencini, Monica Bocchia
Nature Reviews. Clinical Oncology|September 6, 2012
Lenalidomide maintenance in myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
Leukemia & Lymphoma|September 21, 2018
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphomaEmanuele Cencini, Alberto Fabbri, Luana Schiattone, et al.
World Journal of Clinical Oncology|November 4, 2021
Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomasEmanuele Cencini, Alberto Fabbri, Bianca Mecacci, et al.
Pageof 28

Showing results (11-20 of 280) with videos related to

Sort By:
Pageof 28
British Journal of Haematology|February 26, 2016
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphomaEmanuele Cencini, Alberto Fabbri, Monica Bocchia
The Journal of Pathology|May 4, 2017
Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disordersEmanuele Cencini, Alberto Fabbri, Monica Bocchia
Nature Reviews. Clinical Oncology|November 20, 2013
Treatment of smoldering multiple myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
American Journal of Blood Research|July 29, 2021
Nivolumab in relapsed/refractory Hodgkin lymphoma: towards a new treatment strategy?Emanuele Cencini, Monica Bocchia, Alberto Fabbri
Clinical Case Reports|December 28, 2020
Daratumumab efficacy in extramedullary orbital myelomaAlessandro Gozzetti, Alfonso Cerase, Monica Bocchia
Cancer|June 26, 2015
Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphomaAlberto Fabbri, Emanuele Cencini, Monica Bocchia
Medical Oncology (Northwood, London, England)|March 8, 2014
Hodgkin's lymphoma as Richter's transformation in chronic lymphocytic leukemiaAlberto Fabbri, Emanuele Cencini, Monica Bocchia
Nature Reviews. Clinical Oncology|September 6, 2012
Lenalidomide maintenance in myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
Leukemia & Lymphoma|September 21, 2018
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphomaEmanuele Cencini, Alberto Fabbri, Luana Schiattone, et al.
World Journal of Clinical Oncology|November 4, 2021
Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomasEmanuele Cencini, Alberto Fabbri, Bianca Mecacci, et al.
Pageof 28